Cudarolimab

TargetMol Chemicals

Cudarolimab

19

2244739-29-3

Antibody

Research Use Only

Cudarolimab

Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1].

3 years

-20°

12352203